1. Home
  2. KEYS vs NTRA Comparison

KEYS vs NTRA Comparison

Compare KEYS & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Keysight Technologies Inc.

KEYS

Keysight Technologies Inc.

N/A

Current Price

$264.62

Market Cap

51.9B

Sector

Industrials

ML Signal

N/A

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$274.96

Market Cap

56.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KEYS
NTRA
Founded
1939
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.9B
56.7B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
KEYS
NTRA
Price
$264.62
$274.96
Analyst Decision
Buy
Strong Buy
Analyst Count
12
23
Target Price
$399.83
★ $412.36
AVG Volume (30 Days)
1.3M
★ 2.0M
Earning Date
11-19-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 39.89
0.65
EPS
★ 5.93
N/A
Revenue
★ $5,375,000,000.00
$210,939,000.00
Revenue This Year
$20.95
$30.72
Revenue Next Year
$7.56
$21.67
P/E Ratio
$47.40
★ N/A
Revenue Growth
★ 7.95
N/A
52 Week Low
$173.36
$181.00
52 Week High
$389.93
$437.41

Technical Indicators

Market Signals
Indicator
KEYS
NTRA
Relative Strength Index (RSI) 32.70 24.66
Support Level N/A $254.83
Resistance Level $320.85 $288.04
Average True Range (ATR) 14.96 19.03
MACD -0.86 -7.70
Stochastic Oscillator 9.60 1.47

Price Performance

Historical Comparison
KEYS
NTRA

About KEYS Keysight Technologies Inc.

Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: